Literature DB >> 402675

Interaction between yohimbine alkaloids and amphetamine in mice.

G A Lambert, W J Lang.   

Abstract

The toxicity (LD50) of the isomers yohimbine, beta-yohimbine, and corynanthine was determined in mice. The LD50 of amphetamine in the presence of a constant dose of a yohimbine isomer and that of the isomer in the presence of a constant dose of amphetamine were determined in aggregated mice. Isobolograms were constructed from these data and used to evaluate the interaction of the yohimbine alkaloids and amphetamine. Beta-yohimbine was found to be approximately twice as toxic as yohimbine and corynanthine about one fifth as toxic. There was a mutual potentiation between the toxicities of yohimbine and amphetamine. Potentiation of the toxicity of amphetamine occurred with beta-yohimbine but the effect was not as marked as with yohimbine. In contrast, corynanthine antagonized the toxicity of amphetamine. The interaction between yohimbine and amphetamine is unlikely to be due to noradrenergic mechanisms but could conceivably involve serotonergic or dopaminergic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402675     DOI: 10.1007/bf00431743

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  A psycho-pharmacological study of some indole alkaloids.

Authors:  S GERSHON; W J LANG
Journal:  Arch Int Pharmacodyn Ther       Date:  1962-01-01

2.  5-hydroxytryptamine antagonists.

Authors:  L GYERMEK
Journal:  Pharmacol Rev       Date:  1961-09       Impact factor: 25.468

3.  Studies on the mechanism of amphetamine toxicity in aggregated mice.

Authors:  E A SWINYARD; L D CLARK; J T MIYAHARA; H H WOLF
Journal:  J Pharmacol Exp Ther       Date:  1961-04       Impact factor: 4.030

4.  Antagonisms and antagonists.

Authors:  S LOEWE
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

5.  [Behavioral aberration and biogenic amines in the brain of methamphetamine-intoxicated mice, with special reference to aggregation effect].

Authors:  I Tanaka; S Funatogawa
Journal:  Seishin Shinkeigaku Zasshi       Date:  1971-02

6.  The effect of yohimbine on brain serotonin metabolism, motor behavior and body temperature of the rat.

Authors:  R Papeschi; T L Sourkes; M B Youdim
Journal:  Eur J Pharmacol       Date:  1971       Impact factor: 4.432

7.  d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.

Authors:  M Raiteri; A Bertollini; F Angelini; G Levi
Journal:  Eur J Pharmacol       Date:  1975-11       Impact factor: 4.432

8.  The pharmacological and anatomical substrates of the amphetamine response in the rat.

Authors:  I Creese; S D Iversen
Journal:  Brain Res       Date:  1975-01-17       Impact factor: 3.252

9.  Structure-action relationship of beta-carbolines as monoamine oxidase inhibitors.

Authors:  W M McIsaac; V Estevez
Journal:  Biochem Pharmacol       Date:  1966-10       Impact factor: 5.858

10.  THE INCREASE IN THE TOXICITY OF YOHIMBINE INDUCED BY IMIPRAMINE AND OTHER DRUGS IN MICE.

Authors:  R M QUINTON
Journal:  Br J Pharmacol Chemother       Date:  1963-08
View more
  2 in total

1.  Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit.

Authors:  R Weitzell; T Tanaka; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

2.  Behavioural effects of the alpha 2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine.

Authors:  D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.